Randomized controlled trial of a clinical decision support system for painful polyneuropathy.

ABSTRACT:

Introduction

Despite the existence of guidelines, painful neuropathy is often inappropriately treated. We sought to determine the effectiveness of a clinical decision support system on guideline-recommended medication use.

Methods

We randomized neurology providers, stratified by subspecialty, to a best practice alert (BPA) linked to a Smartset or a BPA alone when seeing patients with neuropathy. The primary outcome was the proportion of patients with uncontrolled nerve pain prescribed a guideline-recommended medication. Generalized estimating equations were used to assess effectiveness.

Results

Seventy-five neurology providers (intervention 38, control 37) treated 2697 patients with neuropathy (intervention 1026, control 671). Providers did not acknowledge the BPA in

SUBMITTER: Reynolds EL 

PROVIDER: S-EPMC12416506 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature